Kyntra Bio, Inc. (KYNB)

Kyntra Bio Revenue

Kyntra Bio had revenue of $3.74M in the quarter ending March 31, 2026, with 36.47% growth. This brings the company's revenue in the last twelve months to $7.44M. In the year 2025, Kyntra Bio had annual revenue of $6.44M, down -78.26%.

• Revenue (ttm): $7.44M
• Revenue Growth: -78.26%
• P/S Ratio: 3.76
• Revenue / Employee: $218,794
• Employees: 34
• Market Cap: 28.11M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.44M	-23.18M	-78.26%
Dec 31, 2024	29.62M	-17.18M	-36.71%
Dec 31, 2023	46.80M	-93.93M	-66.74%
Dec 31, 2022	140.73M	-94.58M	-40.19%
Dec 31, 2021	235.31M	58.99M	33.46%
Dec 31, 2020	176.32M	-80.26M	-31.28%
Dec 31, 2019	256.58M	43.62M	20.48%
Dec 31, 2018	212.96M	81.96M	62.57%
Dec 31, 2017	131.00M	-52.19M	-28.49%
Dec 31, 2016	183.19M	2.36M	1.31%
Dec 31, 2015	180.83M	43.23M	31.41%
Dec 31, 2014	137.60M	35.43M	34.68%
Dec 31, 2013	102.17M	36.24M	54.96%
Dec 31, 2012	65.93M	-	-

Data Source: Fiscal.ai Last updated: May 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error